Neurogenic inflammation has been suggested to be involved in migraine affecting altered cytokine levels. Janu Thuraiaiyah, MD, PhD, Danish Headache Center, University of Copenhagen, Glostrup, Denmark, discusses the current knowledge on cytokine levels in migraine patients during and outside attacks. Various studies have looked at the levels of both anti-inflammatory and pro-inflammatory cytokines, and the findings suggest a possible involvement of cytokines in the proposed inflammatory mechanisms of migraine. However, further studies are needed to better understand the exact role of cytokines in migraine pathophysiology. This interview took place at the 16th European Headache Congress (EHC) in Vienna, Austria.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.